By 2021, after several funding rounds, Ro hit a $5 billion valuation
Although early studies have shown promising Retatrutide weight loss results, future availability in the UK will depend on further clinical evidence and regulatory review
The reductions in MI, stroke, and CV death suggest a targeted impact on atherosclerotic processes, rather than acute hemodynamic effects
Ros menu is almost entirely FDA-approved: Wegovy, Zepbound, Foundayo (approved April 1, 2026), and Ozempic off-label
Kong FJ, Wu JH, Sun SY, Ma LL, Zhou JQ
Inject one day early before your trip, then take your next dose up to two days late after you return (semaglutide) or up to four days late (tirzepatide missed dose window)